References
- MartínezFDevesaMCoroleuBCancer and fertility preservation: Barcelona consensus meetingGynecol Endocrinol201329428529123347067
- American Cancer SocietyBreast Cancer Facts and Figures 2009–2010Atlanta, GAAmerican Cancer Society Inc2009 Available from: http://www.cancer.org/acs/groups/content/@nho/documents/document/f861009final90809pdf.pdf+Accessed October 10, 2013
- PollánMMichelenaMJArdanazEIzquierdoASánchez-PérezMJTorrellaABreast Cancer Working GroupBreast cancer incidence in Spain before, during and after the implementation of screening programmesAnn Oncol201021Suppl 3iii97iii10220427367
- PartridgeAHGelberSPeppercornJWeb-based survey of fertility issues in young women with breast cancerJ Clin Oncol200422204174418315483028
- LorenAWManguPBBeckLNAmerican Society of Clinical OncologyFertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline updateJ Clin Oncol201331192500251023715580
- SönmezerMTürkçüoğluICoşkunUOktayKRandom-start controlled ovarian hyperstimulation for emergency fertility preservation in letrozole cyclesFertil Steril20119562125 e9–e11.21292255
- KuwayamaMVajtaGKatoOLeiboSPHighly efficient vitrification method for cryopreservation of human oocytesReprod Biomed Online200511330030816176668
- AlbanoCFelberbaumRESmitzJOvarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study GroupHum Reprod200015352653110686191
- Al-InanyHGAbou-SettaAMAboulgharMGonadotrophin-releasing hormone antagonists for assisted conception: a Cochrane reviewReprod Biomed Online200714564064917509210
- GalindoABodriDGuillénJJColodrónMVernaeveVCollOTriggering with HCG or GnRH agonist in GnRH antagonist treated oocyte donation cycles: a randomised clinical trialGynecol Endocrinol2009251606619165664
- FatemiHMBlockeelCDevroeyPOvarian stimulation: today and tomorrowCurr Pharm Biotechnol201213339239721657998
- CooperTGNoonanEvon EckardsteinsSWorld Health Organization reference values for human semen characteristicsHum Reprod Update201016323124519934213
- OzkayaESan RomanGOktayKLuteal phase GnRHa trigger in random start fertility preservation cyclesJ Assist Reprod Genet201229650350522492220
- NayakSRWakimANRandom-start gonadotropin-releasing hormone (GnRH) antagonist-treated cycles with GnRH agonist trigger for fertility preservationFertil Steril2011961e51e5421601193
- KuangYHongQChenQLuteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cyclesFertil Steril2014101110511124161646
- CoboAKuwayamaMPérezSRuizAPellicerARemohíJComparison of concomitant outcome achieved with fresh and cryopreserved donor oocytes vitrified by the Cryotop methodFertil Steril20088961657166417889865
- Checa VizcaínoMACorchadoARCuadriMEComadranMGBrassescoMCarrerasRThe effects of letrozole on ovarian stimulation for fertility preservation in cancer-affected womenReprod Biomed Online201224660661022503276
- BudakEGarridoNSoaresSRImprovements achieved in an oocyte donation program over a 10-year period: sequential increase in implantation and pregnancy rates and decrease in high-order multiple pregnanciesFertil Steril200788234234917335819
- MeloMAGarridoNAlvarezCAntral follicle count (AFC) can be used in the prediction of ovarian response but cannot predict the oocyte/embryo quality or the in vitro fertilization outcome in an egg donation programFertil Steril200991114815618455166
- ChecaMAPratMCarrerasRAntral follicle count as a predictor of hyperresponse in controlled ovarian hyperstimulation/intrauterine insemination in unexplained sterilityFertil Steril20109431105110720045519